Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Oncology Letters|July 9, 2024
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practiceShigeo Shimose, Issei Saeki, Tetsu Tomonari, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Antitumor effects and immune-mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinomaTakanori Ito, Shigeo Shimose, Joji Tani, et al.
Plos One|September 25, 2024
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapyIssei Saeki, Shigeo Shimose, Tetsu Tomonari, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 21, 2025
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter StudyTakeshi Hatanaka, Shigeo Shimose, Takanori Ito, et al.
Pageof 10